GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » Mentor Capital Inc (OTCPK:MNTR) » Definitions » 5-Year EBITDA Growth Rate

Mentor Capital (Mentor Capital) 5-Year EBITDA Growth Rate : 0.00% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Mentor Capital 5-Year EBITDA Growth Rate?

Mentor Capital's EBITDA per Share for the three months ended in Dec. 2023 was $0.10.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Mentor Capital was 44.10% per year. The lowest was -56.90% per year. And the median was 7.15% per year.

Competitive Comparison of Mentor Capital's 5-Year EBITDA Growth Rate

For the Capital Markets subindustry, Mentor Capital's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mentor Capital's 5-Year EBITDA Growth Rate Distribution in the Capital Markets Industry

For the Capital Markets industry and Financial Services sector, Mentor Capital's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Mentor Capital's 5-Year EBITDA Growth Rate falls into.


Mentor Capital 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Mentor Capital  (OTCPK:MNTR) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Mentor Capital 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Mentor Capital's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Mentor Capital (Mentor Capital) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » Mentor Capital Inc (OTCPK:MNTR) » Definitions » 5-Year EBITDA Growth Rate
Comparable Companies
MGHL NHMD NIHK BETSF MGTI CCTL LGHL VTXB SYSX MVCO MS GS SCHW ASX:MQG SHSE:600030 BSP:BPAC3 RJF TW LPLA SHSE:601066
Traded in Other Exchanges
N/A
Address
5964 Campus Court, Plano, TX, USA, 75093
Website
https://www.mentorcapital.com
Mentor Capital Inc acquires and provides liquidity for medical and social use cannabis companies. The company is operating an acquisition and investment business. It operates through two segments namely the historic cannabis and medical marijuana segment, and the Company's legacy investment in WCI, which works with business park owners, governmental centers, and apartment complexes to reduce their facility-related operating costs. The cannabis and medical marijuana segment include the operation of subsidiaries in the Cannabis and medical marijuana sector. Mentor's focus is medical and the company seeks to facilitate the application of cannabis to cancer wasting, calming seizures, and Parkinson's disease, reducing ocular pressures from glaucoma, and blunting chronic pain.
Executives
David G. Carlile director 10901 BULLRUSH DRIVE, VENICE FL 34293
Lori Stansfield officer: Chief Financial Officer 903 N. TOWNER STREET, SANTA ANA CA 92703
Chester Billingsley director, 10 percent owner, officer: Chief Executive Officer 5964 CAMPUS COURT, PLANO TX 75093
Stan Shaul director 2586 CLAYBOURNE COURT, NEWBURY PARK CA 91320
Robert Bernhard Meyer director 24446 CASWELL COURT, LAGUNA NIGUEL CA 92677
Earl Kornbrekke director 458 DEHARO LANE, FRIDAY HARBOR WA 98250
James Blazeck director 536 OVERLOOK DRIVE, PITTSBURG PA 15216